Roundhill GLP-1 & Weight Loss ETF

OZEM

Market cap $36.2M

If you are looking for the best exchange-traded funds to buy, step back for a second and think big picture instead. Long-term investing requires a plan and shouldn't be handled with off-the-cuff decisions.

Wall Street soared last week as strong jobs data and easing trade tensions sparked market optimism.

The U.S. stocks disappointed investors in Feb amid slowdown concerns and tariffs. These ETFs still gained in double digits.

For many of us, a new year often means a new chance to start fresh in our battle with weight. Thanks to interesting ETF product development, especially in the past year, it could also mean a chance to consider the investment opportunity in weight loss as a theme.

2024 was an amazing year for investment performance, with the broad market S&P 500 TR Index up over 28%. There were also some serious ETF milestones achieved this year.

Medical breakthroughs are occurring constantly, but they often get lost in the news headlines unless they directly impact our lives. I wanted to take a moment to highlight a few recent medical breakthroughs and developments and explore a few ways to get actionable exposure to them with ETFs.

With the completion of a close presidential election, roughly half of us are likely disappointed regardless of the winner. To counter the post-election blues, I identified some “happy” ETF themes to consider for investment.

Investors seeking to tap the boom in weight-loss drug treatment could consider these ETFs.

Dave Mazza, Roundhill Investments CEO, joins CNBC's Bob Pisani on “Halftime Report's” “ETF Edge” segment to discuss the firms' three ETFs following the Mag7, AI and GLP-1 themes.

When markets correct, it is a good time to revisit which equity market sectors are “defensive” themes. Certain products and services are nondiscretionary in nature that we cannot live without.